Simultaneous use of multiplex ligation‐dependent probe amplification assay and flow cytometric DNA ploidy analysis in patients with acute leukemia

Background The aim of this work was to simultaneously use multiplex ligation‐dependent probe amplification (MLPA) assay and flow cytometric DNA ploidy analysis (FPA) to detect aneuploidy in patients with newly diagnosed acute leukemia. Methods MLPA assay and propidium iodide FPA were used to test sa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cytometry. Part B, Clinical cytometry Clinical cytometry, 2018-01, Vol.94 (1), p.172-181
Hauptverfasser: Reyes‐Núñez, Virginia, Galo‐Hooker, Evelyn, Pérez‐Romano, Beatriz, Duque, Ricardo E., Ruiz‐Arguelles, Alejandro, Garcés‐Eisele, Javier
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background The aim of this work was to simultaneously use multiplex ligation‐dependent probe amplification (MLPA) assay and flow cytometric DNA ploidy analysis (FPA) to detect aneuploidy in patients with newly diagnosed acute leukemia. Methods MLPA assay and propidium iodide FPA were used to test samples from 53 consecutive patients with newly diagnosed acute leukemia referred to our laboratory for immunophenotyping. Results were compared by nonparametric statistics. Results The combined use of both methods significantly increased the rate of detection of aneuploidy as compared to that obtained by each method alone. The limitations of one method are somehow countervailed by the other and vice versa. Conclusions MPLA and FPA yield different yet complementary information concerning aneuploidy in acute leukemia. The simultaneous use of both methods might be recommended in the clinical setting. © 2017 International Clinical Cytometry Society
ISSN:1552-4949
1552-4957
DOI:10.1002/cyto.b.21523